>
>

Aquaculture Vaccines Market – By Vaccine Type, By Route of Administration, By Application, By Species – Global Forecast, 2025 – 2034

Download Free PDF

Aquaculture Vaccines Market Size

The global aquaculture vaccines market size was valued at USD 407.4 million in 2024 and is estimated to grow at a CAGR of 8% from 2025 to 2034. The rise of the market can be attributed to the increasing global appetite for seafood and the sustainable practices that aquaculture industry seeks to promote. Vaccination is the most efficient approach to mitigating antibiotic use and economic losses associated with infections to meet the growing demand for aquaculture.
 

Aquaculture Vaccines Market

As per the statistics of the Food and Agriculture Organization, the volume of global fish production amounted to 186.6 million metric tons in 2023, 0.6% more than 2022 levels, principally driven by expansion and intensification of aquaculture activities. As fish farming grows to address the dietary requirements of people, the sector struggles with disease outbreaks among fish that can severely hamper productivity and profits. 
 

To curb these economic losses, the authorities and governments across the world are advocating aquaculture vaccination programs as a means of improving farmed fish welfare, thereby stimulating the market growth. Also, the improvement of vaccine development technology like recombinant DNA and subunit vaccines, which increase potency and decrease the adverse reactions has also contributed towards the market growth.
 

Aquaculture vaccines are biological preparations employed to prevent and manage infectious diseases of aquatic animals within the aquaculture industry. These vaccines aid in the improvement of animal wellbeing, increase production efficiency, and foster antibiotic cessation which promotes sustainable aquaculture.
 

Aquaculture Vaccines Market Trends

Surging in the global aquaculture production to meet the rising demand for seafood will have a positive impact on the market.
 

  • As per the 2024 edition of The State of World Fisheries and Aquaculture (SOFIA), global fisheries and aquaculture production in 2022 surged to 223.2 million tonnes, a 4.4% increase from the year 2020. The report also stated that, in the period 1990–2020, total world aquaculture expanded by 609% in annual output with an average growth rate of 6.7% per year.
     
  • As aquaculture production scales to meet the increasing demand, the need for vaccines to maintain the health of farmed fish and other aquatic organisms is on the rise.
     
  • Also, stricter health standards and monitoring systems governments and regulatory authorities further boosts the adoption of aquaculture vaccines.
     
  • Rapid developments in vaccine technologies such as the formulation of immersion or spray vaccines, has improved the vaccine delivery mechanisms, reducing the dependency of aquaculture farmers ton antibiotics, thus further strengthening the market growth.
     

Aquaculture Vaccines Market Analysis

Aquaculture Vaccines Market, By Vaccine Type, 2021 – 2034 (USD Million)

Based on vaccine type, the global market is segmented into inactivated vaccine, live attenuated vaccine, subunit vaccine, and other vaccine types. The inactivated vaccine segment dominated the market and was valued at USD 302.6 million in 2024.
 

  • Inactivated vaccines are widely used in the aquaculture industry owing to their high effectiveness in the control of fish and shellfish diseases caused by bacteria, viruses and parasites.
     
  • Further, due to their stability and ease of handling, the inactivated vaccines do not need strict cold chain conditions, and this makes them ideal for distribution in different climates including areas that are hard to reach.
     
  • Additionally, the availability of a large number of inactivated aquaculture vaccines in the market, coupled with their proven efficacy in disease prevention drives the market share of inactivated vaccines segment.
     

Based on the route of administration, the aquaculture vaccines market is categorized into injection vaccines, immersion and spray, and oral vaccines. The injection vaccines segment accounted for the highest market share of 60.8% in 2024.
 

  • The segment of injection vaccines accounts for a substantial share in the market because of the targeted protection it offers against a broad spectrum of aquatic diseases.
     
  • Injections are the most employed in aquaculture farming as these are highly effective in containing and preventing the spread of bacterial and viral diseases. These vaccines are injected into the bloodstream of fish for faster immune response and long-term immune retention.
     
  • Also, they provide high levels of immunity against major pathogens such as Vibrio, Aeromonas, and other viruses which can result in substantial losses for aquaculture.
     

Based on the application, the global aquaculture vaccines market is categorized into bacterial, viral, parasitic, and combined. The bacterial segment dominated the market in 2024 and is anticipated to reach USD 430.4 million by 2034.
 

  • Bacterial vaccines are widely used in the aquaculture industry to curb the rising incidence of bacterial diseases in fish and shellfish farming. Bacterial diseases in fish negatively impact the aquaculture industry due to high mortality and decreased productivity resulting in significant economic loss.
     
  • Additionally, availability of advanced bacterial vaccines, especially multivalent and recombinant vaccines, has improved disease prevention measures making this a dominant segment in the market.
     
  • In addition, the growing need for sustainable and non-antibiotic dependent aquaculture practices has further accelerated the adoption of bacterial vaccines which provide good protection without promoting antibiotic resistance.  All these factors together aid in high segmental growth.
     
Aquaculture Vaccines Market, By Species (2024)

Based on species, the aquaculture vaccines market is segmented into salmon, trout, tilapia, seabass, seabream, turbot, carp, and other species. The salmon segment is expected to grow at 8.1% CAGR over the analysis period.
 

  • Salmon is a major contributor in the aquaculture industry and is a key species produced in serval countries such as Norway, Chile, and Scotland. Owing to this high production of salmon, aquaculture vaccines tailored for salmon are in high demand.
     
  • Further, salmon is affected by a range of viral and bacterial pathogens, such as pancreas disease (PD), salmonid rickettsial septicemia (SRS), infectious pancreatic necrosis (IPN), infectious salmon anemia (ISA), and gill disease (GD). This has driven the demand for effective vaccines as the effects of these diseases can have major economic impacts on industry.
     
  • Also, growing demand for fish protein adds more pressure on the wild fish reserve, thus leading to growth in salmon aquaculture business.
     
Norway Aquaculture Vaccines Market, 2021- 2034 (USD Million)

The European region dominates the aquaculture vaccines market. In 2024, the Norway held a significant position in the European market and was valued at USD 85.4 million.
 

  • Norway holds a strong foothold in the Europe as well global market mainly due to the strong aquaculture industry in the country.
     
  • In 2022, Norway's aquaculture production surpassed that of the entire Europe, with 1.66 million tonnes produced, most of which was salmon.
     
  • Being one of the frontrunners in aquaculture salmon production, Norway’s fishery farming sector is vaccine dependent for its fish stock health.
     
  • Additionally, numerous vaccine manufacturing and distribution companies within the country ensures a reliable supply for the growing requirements of disease control in the aquaculture sector, thereby driving the market growth.
     

The aquaculture vaccines market in Asia Pacific is estimated to grow at a CAGR of 8.6% over the next few years.
 

  • The Asia Pacific region contributes significantly to the global aquaculture seafood production, with countries such as with China and Vietnam leading the production.
     
  • In 2022, the aquaculture production in China was the highest in the Asia Pacific region, with over 75 million metric tonnes. Owing to the high production of aquaculture in the region, the demand for aquaculture vaccines is high.
     
  • Moreover, the increase in aquaculture activities in the Asia Pacific region has led to a concurrent increase in government funding and assistance intended for fish health and production improvement, which further solidifies the regional market growth.
     

Brazil's aquaculture vaccines market is projected to witness growth in coming years.
 

  • As a result of its large fish farming industry and suitable climatic conditions for fish cultivation, Brazil possesses a noteworthy share in the Latin America market.
     
  • The country is one of the highest tilapia and shrimp producers which has motivated the use of vaccines to maintain the health and yield of fish species.
     
  • Further, Brazil's strong aquaculture industry is supported by the sustained research and development of vaccine formulation which tries to meet the rising challenges of aquaculture such as bacterial and viral diseases.
     
  • Government investment in sustainable aquaculture technologies as well as a robust regulatory environment further enhances the market growth.
     

Egypt is anticipated to grow in the Middle East and African aquaculture vaccines market.
 

  • Aquaculture is currently the largest single source of fish supply in Egypt accounting for almost 65% of the total fish production of the country with over 99% produced from privately owned farms.
     
  • Thus, with a large number of fish farms, Egypt is a key producer of aquaculture in the Middle East and Africa region, making it a key market for aquaculture vaccines.
     
  • Also, with increasing population the demand for fish as a source of protein is on the rise, which further boosts aquaculture farming and the need for effective vaccines.
     

Aquaculture Vaccines Market Share

The market is evolving due to the need for more sustainable aquaculture and the increased focus on disease management in fish farming. The market is composed of large multinational pharmaceutical companies, a few specialized vaccine companies, and biotechnology companies, all competing to offer the innovative and economically feasible options. Merck Animal Health, Zoetis, and Elanco are some of the sector leaders with expansion potential backed by their global distribution capabilities as well as robust research and development onto vaccines across a diverse range of fish species. Vendors are investing in product launches, geographical expansions, collaborative agreements, and acquisitions to sustain themselves in the market.
 

Apart from the well-established players, smaller regional players also form a part of the market with their niche product offerings. These players offer solutions tailored for local regional diseases at a low cost. Industry partnerships, mergers, and new product innovations are key growth areas that the market players explore to enhance their global footprint.
 

Aquaculture Vaccines Market Companies

Few of the prominent players operating in the aquaculture vaccines industry include:

  • CIBA
  • HIPRA
  • Kyoto Biken Laboratories
  • Kemin Industries
  • Kyoritsuseiyaku Corporation
  • Merck Animal Health (Merck & Co.) 
  • Nisseiken
  • Phibro Animal Health Corporation
  • Tecnovax
  • Virbac
  • Veterquimica
  • Vaxxinova International
  • Zoetis
     

USPs of top players:

  • Companies offer customized vaccines tailored to specific aquaculture species.
     
  • Vast distribution networks help the market players to cater to a large customer base.
     
  • Partnerships and collaborations with local regional players aid in better market penetration.
     

Aquaculture Vaccines Industry News

  • In August 2024, ICAR-Central Institute of Brackishwater Aquaculture (ICAR-CIBA), Chennai signed a partnership agreement with Indian Immunologicals Limited, Hyderabad for the commercial development of CIBA vaccine “Nodavac-R” against viral nervous necrosis in finfishes. This collaboration significantly enhances CIBA's role in advancing aquaculture health solutions, contributing to both scientific innovation and economic growth within the sector.
     
  • In July 2024, Merck Animal Health completed the acquisition of the aqua business of Elanco Animal Health Incorporated. The completion of this acquisition bolsters Merck Animal Health’s position in the aqua industry with a comprehensive approach to promote fish health, welfare and sustainability in aquaculture, conservation, and fisheries.
     

The aquaculture vaccines market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Vaccine Type

  • Inactivated vaccine
  • Live attenuated vaccine
  • Subunit vaccine
  • Other vaccine types

Market, By Route of Administration

  • Injection vaccines
  • Immersion and spray
  • Oral vaccines

Market, By Application

  • Bacterial
  • Viral
  • Parasitic
  • Combined

Market, By Species

  • Salmon
  • Trout
  • Tilapia
  • Seabass
  • Seabream
  • Turbot
  • Carp
  • Other species

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Norway
    • Ireland
    • Turkey
    • Denmark
  • Asia Pacific
    • China
    • India
    • Indonesia
    • Philippines
    • Thailand
    • Vietnam
    • Australia
    • New Zealand 
  • Latin America
    • Brazil
    • Mexico
    • Chile
  • Middle East and Africa
    • Iran
    • Egypt

 

Authors: Mariam Faizullabhoy, Gauri Wani
Frequently Asked Question(FAQ) :
Who are some of the prominent players in the aquaculture vaccines industry?
Key players in the sector include CIBA, HIPRA, Kyoto Biken Laboratories, Kemin Industries, Kyoritsuseiyaku Corporation, Merck Animal Health (a division of Merck & Co.), Nisseiken, Phibro Animal Health Corporation, Tecnovax, Virbac, and Veterquimica.
How much is the European aquaculture vaccines market worth?
Why is the inactivated vaccine segment dominating the market?
How big is the aquaculture vaccines market?
Aquaculture Vaccines Market Scope
  • Aquaculture Vaccines Market Size
  • Aquaculture Vaccines Market Trends
  • Aquaculture Vaccines Market Analysis
  • Aquaculture Vaccines Market Share
Related Reports
    Authors: Mariam Faizullabhoy, Gauri Wani
    Buy Now
    $4,123 $4,850
    15% off
    $4,840 $6,050
    20% off
    $5,845 $8,350
    30% off
        Buy now
    Premium Report Details

    Base Year: 2024

    Companies covered: 13

    Tables & Figures: 102

    Countries covered: 24

    Pages: 135

    Download Free PDF

    Top